Eswatini vs Haiti: HIV/AIDS deaths averted by antiretroviral therapy
Eswatini
10,530 deaths
in 2024
Haiti
8,513 deaths
in 2024
Eswatini rank
24th
Haiti rank
27th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Eswatini
- Haiti
How they compare
Eswatini currently reports 10,530 deaths against 8,513 deaths in Haiti, a difference of 2,017 deaths.
That makes Eswatini's figure about 1.2 times Haiti's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Haiti ahead.
Eswatini ranks 24th and Haiti ranks 27th of 157 countries.
Eswatini has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Eswatini | Haiti | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 2,256 deaths | 1,003 deaths | 1,253 deaths | Eswatini |
| 2010s | 9,542 deaths | 4,307 deaths | 5,235 deaths | Eswatini |
| 2020s | 10,848 deaths | 8,123 deaths | 2,725 deaths | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Eswatini or Haiti?
- Eswatini, at 10,530 deaths against 8,513 deaths in Haiti as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Eswatini and Haiti?
- 2,017 deaths, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Haiti?
- 35 years are reported by both, from 1990 to 2024.
- How do Eswatini and Haiti rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Eswatini ranks 24th and Haiti ranks 27th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.